• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Nasr, N. (2021). ROLE OF MAGNETIC RESONANCE IMAGING TO DIFFERENTIATE BETWEEN GLIOBLASTOMA AND PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: RETROSPECTIVE STUDY. ALEXMED ePosters, 3(2), 71-72. doi: 10.21608/alexpo.2021.81931.1189
Nahla Ibrahim Nasr. "ROLE OF MAGNETIC RESONANCE IMAGING TO DIFFERENTIATE BETWEEN GLIOBLASTOMA AND PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: RETROSPECTIVE STUDY". ALEXMED ePosters, 3, 2, 2021, 71-72. doi: 10.21608/alexpo.2021.81931.1189
Nasr, N. (2021). 'ROLE OF MAGNETIC RESONANCE IMAGING TO DIFFERENTIATE BETWEEN GLIOBLASTOMA AND PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: RETROSPECTIVE STUDY', ALEXMED ePosters, 3(2), pp. 71-72. doi: 10.21608/alexpo.2021.81931.1189
Nasr, N. ROLE OF MAGNETIC RESONANCE IMAGING TO DIFFERENTIATE BETWEEN GLIOBLASTOMA AND PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: RETROSPECTIVE STUDY. ALEXMED ePosters, 2021; 3(2): 71-72. doi: 10.21608/alexpo.2021.81931.1189

ROLE OF MAGNETIC RESONANCE IMAGING TO DIFFERENTIATE BETWEEN GLIOBLASTOMA AND PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: RETROSPECTIVE STUDY

Article 139, Volume 3, Issue 2, June 2021, Page 71-72  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.81931.1189
View on SCiNiTO View on SCiNiTO
Author
Nahla Ibrahim Nasr email
Department of Radiodiagnosis, Faculty of Medicine, Alexandria University
Abstract
Preoperative differentiation of primary central nervous system lymphomas (PCNSLs) and glioblastomas is of high clinical relevance because treatment strategies for glioblastoma and PCNSL vary substantially. In patients with glioblastoma, gross total resection followed by radiation therapy and chemotherapy with temozolomide is the treatment of choice, whereas patients with PCNSL usually undergo stereotactic biopsy followed by high dose methotrexate-based chemotherapy.
Standard magnetic resonance (MR) imaging sequences allow differentiation for most patients because PCNSL in immunocompetent patients usually appears as a homogeneous enhancement on contrast material–enhanced T1-weighted MR images, but glioblastomas usually exhibit a ring or ringlike zone of contrast enhancement around a hypointense central area of necrosis. A T2 hyperintense edema surrounds both tumors. Diffusion weighted imaging a well established advanced an MR technique has been reported to improve the differential diagnosis between PCNSL and GBM. Water diffusion can be measured with a parameter of apparent diffusion coefficient (ADC). Highly cellular tumors like PCNSL show areas of restricted diffusion with low ADC values, thus ADC is regarded as a marker of tumor cellularity.
Keywords
MRI; GLIOBLASTOMA; PCNSL
Supplementary Files
download 0071-1189 Presentation10 (3).pdf
Statistics
Article View: 119
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.